Washington Trust’s Tenet Healthcare THC Stock Holding History

Washington Trust’s Portfolio THC Stock Details THC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-100	Closed	-$4.88K	–	991
2022 Q4	$4.88K	Hold	100	–	–	﹤0.01%	725
2022 Q3	$5K	Buy	+100	New	+$5.93K	﹤0.01%	724

Other funds holding THC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GCM

Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Washington Trust's THC Position: Q1 2023 in Review

Washington Trust sold out of Tenet Healthcare (THC) in Q1 2023, closing a stake of 100 shares — an estimated $4.88K sold.

Washington Trust first reported a position in THC in Q3 2022 and held it in 2 quarters. The position peaked at $5K in Q3 2022. 365 funds tracked by Wall St. Rank hold THC as of Q1 2023.

Washington Trust reported no remaining Tenet Healthcare position as of Q1 2023 after selling out during the quarter.
Washington Trust sold 100 Tenet Healthcare shares in Q1 2023, an estimated $4.88K.
Washington Trust first reported a position in Tenet Healthcare in Q3 2022 and held it in 2 quarters.
Washington Trust's Tenet Healthcare position peaked at $5K in Q3 2022.
365 funds tracked by Wall St. Rank held Tenet Healthcare as of Q1 2023.

Based on Washington Trust's 13F filing for Q1 2023, filed 4 May 2023.